Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Alliqua BioMedical, Inc

Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors
Newly Nasdaq-traded Adynxx (ADYX) focused on development of novel, non-opioid therapeutics for the treatment of pain and inflammatory diseases 
Tickers ADYX ALQA
From GlobeNewswire News Releases
Alliqua BioMedical CEO Provides Update to Shareholders
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the Contingent Special Dividend and the Spin-Off of Contract Manufacturing Business
Alliqua BioMedical, Inc. (Nasdaq: ALQA) announced today that its Board of Directors has declared a special cash dividend of $1.05 for each share of common stock outstanding as of the close of business... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua Biomedical CEO Provides Update to Shareholders
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals LLC to Create an Independent, Publicly Traded Company focused on Cannabinoid-Based Pharmaceutical T
Alliqua BioMedical, Inc. (Nasdaq: ALQA) and TO Pharmaceuticals LLC, a privately held cannabinoid-based pharmaceutical therapy company (“TOP”), today announced plans for Alliqua to spin off its AquaMed... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
Alliqua BioMedical, Inc. (Nasdaq:ALQA) and Adynxx, Inc., a privately held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces Closing Asset Sale to Celularity Inc.
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced that it has completed its previously announced asset sale to Celularity... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc.
Alliqua BioMedical, Inc. (NASDAQ:ALQA) (“Alliqua or the “Company”), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced a definitive agreement with... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook
Q3’17 Product revenue from continuing operations increased 14% year-over-year, led by Biologics growth of 70% year-over-year 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced that it has engaged Cowen as... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative medicine company committed to restoring tissue and rebuilding lives, today announced plans to release third quarter... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split
Shares of Common Stock Will Begin Trading on Split-Adjusted Basis on October 6, 2017 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook
Alliqua BioMedical, Inc. (NASDAQ:ALQA) (“Alliqua or the “Company”), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced that Alliqua sold all assets... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial Results
Q2’17 Product revenue from continuing operations increased 34% year-over-year, led by Biologics growth of 106% year-over-year 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. to Announce Second Quarter of Fiscal Year 2017 Results on August 10th
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative medicine company committed to restoring tissue and rebuilding lives, today announced plans to release second quarter... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces Partnership with Partners Capital Group to Provide UltraMIST® Customers with New Equipment Financing Programs
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced that it has entered into a... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Reports First Quarter of Fiscal Year 2017 Financial Results
Q1’17 Product revenue from continuing operations increased 28% year-over-year, led by Biologics growth of 197% year-over-year 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced that the Listing... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook; Earnings Conference Call Scheduled for May 9, 2017
Preliminary Q1’17 product sales increase 28% year-over-year led by biologics growth of approximately 200% year-over-year 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. to Present New Data at the Spring 2017 Symposium on Advanced Wound Care
Features Five New Poster Presentations on Interfyl™ and UltraMIST® Therapy 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces Closing of Approximately $3.8 Million Public Offering
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced the closing of its... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces Pricing of Public Offering of Common Stock
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced the pricing of an... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces Proposed Public Offering of Common Stock
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced that it intends to offer and... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces the Publication of a Peer-reviewed Study Examining the Use of MIST Therapy for Deep Tissue Pressure Injuries
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced the publication of a... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results
FY’16 Product revenue from continuing operations increased 60% year-over-year, led by Biologics growth in excess of 115% year-over-year 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. to Present at the Cowen and Company 37th Annual Health Care Conference on March 8th
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced that David Johnson, Chief... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. to Announce Fourth Quarter and Fiscal Year 2016 Results on March 7th
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced plans to release fourth... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces the Closing of Approximately $2.8 Million Private Placement
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced that investors have agreed... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Announces Termination of its Agreement to Acquire Soluble Systems, LLC
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced the termination of its... 
Tickers ALQA
From GlobeNewswire News Releases
Alliqua BioMedical, Inc. Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results
Third Quarter Product Revenue Growth of 18% year-over-year 
Tickers ALQA
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.